These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 8051547)

  • 1. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
    Graber D; Salvayre R; Levade T
    J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
    Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
    Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelinase and nonspecific phosphodiesterase activities in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A, B and C.
    Levade T; Salvayre R; Lenoir G; Douste-Blazy L
    Biochim Biophys Acta; 1984 Apr; 793(2):321-4. PubMed ID: 6324871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.
    Levade T; Salvayre R; Bes JC; Nezri M; Douste-Blazy L
    Pediatr Res; 1985 Jan; 19(1):153-7. PubMed ID: 2982124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for both endogenous and exogenous sources of the sphingomyelin storage in lymphoid cell lines from patients with Niemann-Pick disease types A and B.
    Levade T; Salvayre R; Maret A; Douste-Blazy L
    J Inherit Metab Dis; 1988; 11(2):151-7. PubMed ID: 3139926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular forms of sphingomyelinase and non-specific phosphodiesterases in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease types A and B.
    Levade T; Salvayre R; Douste-Blazy L
    Eur J Biochem; 1985 Jun; 149(2):405-9. PubMed ID: 2986976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different pathways of uptake and degradation of sphingomyelin by lymphoblastoid cells and the potential participation of the neutral sphingomyelinase.
    Levade T; Gatt S; Maret A; Salvayre R
    J Biol Chem; 1991 Jul; 266(21):13519-29. PubMed ID: 1649823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of ceramide-labeled sphingomyelin.
    Levade T; Leruth M; Graber D; Moisand A; Vermeersch S; Salvayre R; Courtoy PJ
    J Lipid Res; 1996 Dec; 37(12):2525-38. PubMed ID: 9017505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.
    Sutrina SL; Chen WW
    Biochim Biophys Acta; 1984 Apr; 793(2):169-79. PubMed ID: 6424713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and degradation of several pyrenesphingomyelins by skin fibroblasts from control subjects and patients with Niemann-Pick disease. Effect of the structure of the fluorescent fatty acyl residue.
    Levade T; Gatt S; Salvayre R
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):211-7. PubMed ID: 2018477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
    Klar R; Levade T; Gatt S
    Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
    He X; Chen F; Gatt S; Schuchman EH
    Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function.
    Marathe S; Miranda SR; Devlin C; Johns A; Kuriakose G; Williams KJ; Schuchman EH; Tabas I
    Hum Mol Genet; 2000 Aug; 9(13):1967-76. PubMed ID: 10942425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases.
    Kudoh T; Velkoff MA; Wenger DA
    Biochim Biophys Acta; 1983 Nov; 754(1):82-92. PubMed ID: 6626569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
    Maor I; Mandel H; Aviram M
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media.
    Thomas GH; Tuck-Muller CM; Miller CS; Reynolds LW
    J Inherit Metab Dis; 1989; 12(2):139-51. PubMed ID: 2547109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms.
    Takahashi T; Suchi M; Desnick RJ; Takada G; Schuchman EH
    J Biol Chem; 1992 Jun; 267(18):12552-8. PubMed ID: 1618760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells.
    Suchi M; Dinur T; Desnick RJ; Gatt S; Pereira L; Gilboa E; Schuchman EH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3227-31. PubMed ID: 1565614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural investigations on two lymphoid cell lines from Niemann-Pick disease type B.
    Bes JC; Salvayre R; Levade T; Caratero C; Planel H
    Biol Cell; 1984; 50(3):299-302. PubMed ID: 6087964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.